Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Kitajima

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
International Journal of Clinical Oncology|January 7, 2023
Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical interventionAkifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, et al.
European Journal of Radiology|May 1, 2016
Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinomaKazuhiro Kitajima, Toshiko Yamano, Kazuhito Fukushima, et al.
European Journal of Radiology|June 4, 2013
Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRIKazuhiro Kitajima, Yuko Suenaga, Yoshiko Ueno, et al.
Japanese Journal of Radiology|July 21, 2021
Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using <sup>18</sup>F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCISTKazuhiro Kitajima, Tadashi Watabe, Masatoyo Nakajo, et al.
Annals of Surgical Oncology|April 4, 2019
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in <sup>18</sup>F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative ChemotherapyTomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, et al.
Placenta|April 9, 2018
A novel scoring system for predicting adherent placenta in women with placenta previaKenji Tanimura, Mayumi Morizane, Masashi Deguchi, et al.
Nuclear Medicine Communications|March 17, 2011
FDG-PET/CT for diagnosis of primary ovarian cancerKazuhiro Kitajima, Kayo Suzuki, Michio Senda, et al.
Clinical Imaging|March 20, 2014
Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRIKazuhiro Kitajima, Yuko Suenaga, Yoshiko Ueno, et al.
Japanese Journal of Radiology|February 28, 2016
SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancerHiroshi Doi, Kazuhiro Kitajima, Kazuhito Fukushima, et al.
Anticancer Research|October 3, 2022
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 InhibitorHiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
International Journal of Clinical Oncology|January 7, 2023
Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical interventionAkifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, et al.
European Journal of Radiology|May 1, 2016
Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinomaKazuhiro Kitajima, Toshiko Yamano, Kazuhito Fukushima, et al.
European Journal of Radiology|June 4, 2013
Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRIKazuhiro Kitajima, Yuko Suenaga, Yoshiko Ueno, et al.
Japanese Journal of Radiology|July 21, 2021
Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using <sup>18</sup>F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCISTKazuhiro Kitajima, Tadashi Watabe, Masatoyo Nakajo, et al.
Annals of Surgical Oncology|April 4, 2019
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in <sup>18</sup>F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative ChemotherapyTomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, et al.
Placenta|April 9, 2018
A novel scoring system for predicting adherent placenta in women with placenta previaKenji Tanimura, Mayumi Morizane, Masashi Deguchi, et al.
Nuclear Medicine Communications|March 17, 2011
FDG-PET/CT for diagnosis of primary ovarian cancerKazuhiro Kitajima, Kayo Suzuki, Michio Senda, et al.
Clinical Imaging|March 20, 2014
Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRIKazuhiro Kitajima, Yuko Suenaga, Yoshiko Ueno, et al.
Japanese Journal of Radiology|February 28, 2016
SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancerHiroshi Doi, Kazuhiro Kitajima, Kazuhito Fukushima, et al.
Anticancer Research|October 3, 2022
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 InhibitorHiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, et al.
Pageof 25